Daughters of patients past and present work together to raise awareness of deadly lung disease

CULVER CITY, Calif., Feb. 12, 2014 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) announced today the launch of a new campaign that will lend greater power to the voices of women who have a parent dying from Pulmonary Fibrosis (PF), or whose parent has lost their lives to the deadly lung disease. The campaign is designed to encourage more women to join the organization's growing Daughters of PF program so that the message about PF's impact will be heard across all corners of the world..

The "A Daughter's Love" campaign is simple: It asks women anywhere in the world who have been touched by PF to remember or honor their loved one by putting their picture in the middle of a heart and posting it on social media and the Daughters of PF Facebook page (https://www.facebook.com/pages/Daughters-of-Pulmonary-Fibrosis/186949891389411) .. They can use a sample provided by Teresa Barnes, VP of the CPF who lost her father to the disease or they can create one of their own.

The campaign begins this week with Valentine's Day in mind, and will continue through the remainder of the year via other Daughters of PF efforts.

"Although most of the members of the Daughters of PF program are actually daughters, there is a growing number who are wives, sisters, nieces, granddaughters and others who want to honor or pay tribute to someone they love with PF," said Mishka Michon, Chief Executive Officer of the Coalition for Pulmonary Fibrosis. "We welcome them all."

The Coalition for Pulmonary Fibrosis works on a national scale to support research for a cure and to assist patients. For information or to support this important work, please contact the CPF at 1-888-222-8541, or visit www.coalitionforpf.org or visit us on Facebook or Twitter.

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring – known as fibrosis — and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501C(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 27,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541

Newswire Distribution Network & Management

About Us

GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.